These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28223247)

  • 1. In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application.
    Colombo M; Staufenbiel S; Rühl E; Bodmeier R
    Int J Pharm; 2017 Apr; 521(1-2):156-166. PubMed ID: 28223247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Drug Brittleness, Nanomilling Time, and Freeze-Drying on the Crystallinity of Poorly Water-Soluble Drugs and Its Implications for Solubility Enhancement.
    Colombo M; Orthmann S; Bellini M; Staufenbiel S; Bodmeier R
    AAPS PharmSciTech; 2017 Oct; 18(7):2437-2445. PubMed ID: 28168626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical-chemical properties of furosemide nanocrystals developed using rotation revolution mixer.
    Barbosa SF; Takatsuka T; Tavares GD; Araújo GL; Wang H; Vehring R; Löbenberg R; Bou-Chacra NA
    Pharm Dev Technol; 2016 Nov; 21(7):812-822. PubMed ID: 27825283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocrystals of medium soluble actives--novel concept for improved dermal delivery and production strategy.
    Zhai X; Lademann J; Keck CM; Müller RH
    Int J Pharm; 2014 Aug; 470(1-2):141-50. PubMed ID: 24813782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method.
    Morakul B; Suksiriworapong J; Chomnawang MT; Langguth P; Junyaprasert VB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):886-96. PubMed ID: 25201298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
    Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
    Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of quercetin nanocrystals: comparison of different methods.
    Kakran M; Shegokar R; Sahoo NG; Shaal LA; Li L; Müller RH
    Eur J Pharm Biopharm; 2012 Jan; 80(1):113-21. PubMed ID: 21896330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
    Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
    Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals.
    Shah S; Parmar B; Soniwala M; Chavda J
    AAPS PharmSciTech; 2016 Oct; 17(5):1150-8. PubMed ID: 26586537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical nanocrystals: production by wet milling and applications.
    Malamatari M; Taylor KMG; Malamataris S; Douroumis D; Kachrimanis K
    Drug Discov Today; 2018 Mar; 23(3):534-547. PubMed ID: 29326082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocrystals for improved dermal drug delivery.
    Pelikh O; Stahr PL; Huang J; Gerst M; Scholz P; Dietrich H; Geisel N; Keck CM
    Eur J Pharm Biopharm; 2018 Jul; 128():170-178. PubMed ID: 29680482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
    Dugar RP; Gajera BY; Dave RH
    AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability of quercetin nanocrystals prepared by different methods.
    Kakran M; Shegokar R; Sahoo NG; Gohla S; Li L; Müller RH
    J Pharm Pharmacol; 2012 Oct; 64(10):1394-402. PubMed ID: 22943170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs.
    Huang Z; Staufenbiel S; Bodmeier R
    Pharm Res; 2022 May; 39(5):949-961. PubMed ID: 35552985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study.
    Chogale M; Gite S; Patravale V
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1763-1775. PubMed ID: 32912040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation.
    Shah SM; Ullah F; Khan S; Shah SM; de Matas M; Hussain Z; Minhas MU; AbdEl-Salam NM; Assi KH; Isreb M
    Drug Des Devel Ther; 2016; 10():3837-3850. PubMed ID: 27920499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lutein nanocrystals as antioxidant formulation for oral and dermal delivery.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Nov; 420(1):141-6. PubMed ID: 21884768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the in vitro dissolution and in vivo pharmacokinetics for different formulation strategies (solid dispersion, micronization, and nanocrystals) for poorly water-soluble drugs: A case study for lacidipine.
    Fu Q; Li B; Zhang D; Fang M; Shao J; Guo M; Guo Z; Li M; Sun J; Zhai Y
    Colloids Surf B Biointerfaces; 2015 Aug; 132():171-6. PubMed ID: 26047880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.